These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9645829)

  • 1. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program.
    Pahor M; Shorr RI; Somes GW; Cushman WC; Ferrucci L; Bailey JE; Elam JT; Applegate WB
    Arch Intern Med; 1998 Jun; 158(12):1340-5. PubMed ID: 9645829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
    Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
    J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
    J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.
    Franse LV; Pahor M; Di Bari M; Somes GW; Cushman WC; Applegate WB
    Hypertension; 2000 May; 35(5):1025-30. PubMed ID: 10818057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    Agarwal R; Sinha AD; Cramer AE; Balmes-Fenwick M; Dickinson JH; Ouyang F; Tu W
    N Engl J Med; 2021 Dec; 385(27):2507-2519. PubMed ID: 34739197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
    Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K
    Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
    Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
    JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
    Roussos L; Christensson A; Thompson O
    Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
    BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension.
    Wang JG; Staessen JA; Fagard RH; Birkenhäger WH; Gong L; Liu L
    Hypertension; 2001 Apr; 37(4):1069-74. PubMed ID: 11304505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
    Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.